Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets...
Vous n'êtes pas connecté
Revolutionizing obesity treatment: Once-monthly injections show promising results, offering a potential breakthrough in weight management.
Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets...
A new study has found that a once-weekly injection of semaglutide, a medication originally developed for diabetes and weight loss, significantly...
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Eli Lilly and Company launched Mounjaro in single─dose vial presentation following the marketing authorization from the Central Drugs Standard...
Eli Lilly and Company launched Mounjaro in single─dose vial presentation following the marketing authorization from the Central Drugs Standard...
Discover the innovation in CBD's solubility and absorption, promising more effective treatments for epilepsy and neurodegenerative diseases.
To increase joint stability and lessen knee stress, conservative management techniques include weight control, strength training, and physiotherapy....
To increase joint stability and lessen knee stress, conservative management techniques include weight control, strength training, and physiotherapy....